CAM
RLMD icon

Concorde Asset Management’s Relmada Therapeutics RLMD Stock Holding History

Concorde Asset Management’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,700
Closed -$433K – 156
2022
Q3 		$433K Buy
+11,700
New +$433K 0.48% 65